NM_017890.5:c.3118T>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_017890.5(VPS13B):​c.3118T>A​(p.Leu1040Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L1040L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

VPS13B
NM_017890.5 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.00500

Publications

0 publications found
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
VPS13B Gene-Disease associations (from GenCC):
  • Cohen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.075084895).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017890.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13B
NM_017890.5
MANE Plus Clinical
c.3118T>Ap.Leu1040Met
missense
Exon 22 of 62NP_060360.3
VPS13B
NM_152564.5
MANE Select
c.3118T>Ap.Leu1040Met
missense
Exon 22 of 62NP_689777.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VPS13B
ENST00000358544.7
TSL:1 MANE Plus Clinical
c.3118T>Ap.Leu1040Met
missense
Exon 22 of 62ENSP00000351346.2
VPS13B
ENST00000357162.7
TSL:1 MANE Select
c.3118T>Ap.Leu1040Met
missense
Exon 22 of 62ENSP00000349685.2
VPS13B
ENST00000355155.6
TSL:1
n.3115T>A
non_coding_transcript_exon
Exon 22 of 28ENSP00000347281.2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cohen syndrome Uncertain:1
Mar 28, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with VPS13B-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with methionine at codon 1040 of the VPS13B protein (p.Leu1040Met). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and methionine.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
9.6
DANN
Benign
0.93
DEOGEN2
Benign
0.056
T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.60
T
M_CAP
Benign
0.0055
T
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
-0.0050
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.10
N
REVEL
Benign
0.0080
Sift
Benign
0.22
T
Sift4G
Benign
0.18
T
Polyphen
0.011
B
Vest4
0.21
MutPred
0.35
Gain of catalytic residue at V1036 (P = 0.0282)
MVP
0.14
MPC
0.12
ClinPred
0.041
T
GERP RS
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.088
gMVP
0.26
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746830200; hg19: chr8-100443800; API